Abstract
We evaluated literature that addresses the notion that flexible smoking treatment approaches are warranted for smokers with a diagnosis of schizophrenia. Understanding the biological and psychological mechanisms that increase the likelihood of smoking and decrease the motivation to quit for these individuals is addressed within the framework of a neurobiological model. We provide a brief overview of the limited smoking cessation treatment literature for patients with schizophrenia and compare abstinence-focused versus reduction-focused treatment modalities. The potential utility of the reduction-focused approach to tobacco treatment for these smokers is evaluated. Suggestions for future research to address the utility and efficacy of reduction-focused interventions for smokers with schizophrenia are put forth. We conclude with a consideration of the implications for the current understanding of smoking treatment among patients with co-morbid psychiatric diagnoses.
Original language | English (US) |
---|---|
Pages (from-to) | 785-793 |
Number of pages | 9 |
Journal | Addiction |
Volume | 97 |
Issue number | 7 |
DOIs | |
State | Published - 2002 |
Externally published | Yes |
Keywords
- Harm reduction
- Nicotine dependence
- Schizophrenia
ASJC Scopus subject areas
- Medicine (miscellaneous)
- Psychiatry and Mental health